Samsung Biologics Sets Q1 Sales Record...Eyes KRW 5T Year 김승권 2025.04.23 오후 04:50 Samsung Biologics Celebrates 14 Years, Accelerates Global Top-Tier GrowthNow the world’s... 송영두 2025.04.22 오전 07:31 Samsung Bioepis unveils new research on autoimmune biosimilars at IMKASID 2025 김진수 2025.04.10 오후 04:34 Samsung Bioepis’ biosimilar EPYSQLI now available in the U.S. 임정요 2025.04.08 오전 11:16 Trump Signs Executive Order to Cut Drug Prices…Benefits for Korean biosimilars? 김새미 2025.04.17 오전 09:11 Peptron, Oncocross Hit Kosdaq Upper Limits as Obesity, AI Drug Themes Rally 임정요 2025.04.14 오전 07:35 Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse] 송영두 2025.04.03 오전 08:08 HLB Starts Rivoceranib Site Planning to Diversify Supply Chain 김진수 2025.04.01 오후 04:51 Samsung Biologics CEO, “Plant 5 to Be Completed in April, Expanding Orders to Global Top 40” 송영두 2025.03.17 오후 12:53 삼성 'ADC 기술 보유' 스위스 바이오텍 투자 김새미 2023.04.12 오후 02:24 더 보기 로딩중..
samsung
samsung
![Oncocross Soars on Diversification Hopes, ABL Bio Slides on Trial Data[K-Bio Pulse]](https://image.edaily.co.kr/images/vision/files/NP/S/2025/04/PS25040300289b.jpg)
